Here you can find the latest news and updates from EUCAST.

14 Mar 2023
Updated QC-tables

The updated QC tables contain new MIC ranges for S. aureus ATCC 29213 and S. pneumoniae ATCC 49619 (ampicillin, amoxicillin, amoxicillin-clavulanic acid, chlortetracycline and oxytetracycline). [more]

20 Feb 2023
Updated files demonstrating the correlation between MIC and inhibition zone diameters.

Files demonstrating the correlation between MIC-values and EUCAST standardised disk diffusion inhibition zone diameters are updated yearly. The 2023 update is now completed. New for this year are files for Vibrio spp. andC....[more]

18 Feb 2023
Br. melitensis and B. anthracis - MIC and zone diameter distributions available

EUCAST will during 2023, based on the work of theEMERGE AST Working Group, strive to publish clinical breakpoints and disk diffusion correlates for Brucella melitensis and Bacillus anthracis. Through the joint effort of the...[more]

18 Feb 2023
EUCAST General Committee meeting Monday 17 April, 2023.

EUCAST General Committee meeting will be held during ECCMID, Copenhagen, Monday 17 April, 9.30 - 10.30, Room 178 (1st Floor Hotel). This is an open meeting and there is no pre-registration. A reminder and an agenda will be...[more]

17 Feb 2023

EUCAST has prepared a statement in response to questions related to how the IVDR will affect users of EUCAST methods and guidance. The statement and a link to the directive are available...[more]

10 Feb 2023
Consultation on clinical breakpoints for anaerobic bacteria - additional agents.

EUCAST has so far included five species/species groups in the breakpoint table for anaerobic bacteria; Bacteroides, Prevotella spp, Fusobacterium necrophorum, Clostridium perfringens and Cutibacterium acnes. This general...[more]

08 Feb 2023
Fosfomycin IV - EUCAST comments and response to consultation

Fosfomycin IV - EUCAST response to the many comments on the fosfomycin consultation during 2022. [more]

Displaying results 29 to 35 out of 522